![Thomas Shepherd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Shepherd
Corporate Officer/Principal bei
CAPTOR THERAPEUTICS SPOLKA AKCYJNA
Profil
Thomas Shepherd currently works at Tom Shepherd Consulting SAS, as Chairman, Neurophoenix SAS, as General Director, and Captor Therapeutics SA, as Senior Vice President-Strategy from 2025.
Dr. Shepherd received his doctorate degree from the University of Strathclyde.
Aktive Positionen von Thomas Shepherd
| Unternehmen | Position | Beginn |
|---|---|---|
| CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Corporate Officer/Principal | - |
Neurophoenix SAS | Vorstandsvorsitzender | - |
Tom Shepherd Consulting SAS | Vorsitzender | - |
Ausbildung von Thomas Shepherd
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
1
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Captor Therapeutics SA
 Captor Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company which develops protein degradation drugs for cancer and autoimmune diseases | Health Technology |
Neurophoenix SAS | |
Tom Shepherd Consulting SAS |
Wählen Sie MarketScreener 
